Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Terry H. Landowski

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112739082. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic c… Co-author PMID 33042633↗
  2. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Last author DOI 10.4161/15384047.2014.986967↗
  3. Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells. First author DOI 10.1158/1541-7786.mcr-11-0359↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Davendra P. S. Sohal · 1 shared paper, 2020 · strength 0.10
  2. Alok A. Khorana · 1 shared paper, 2020 · strength 0.10
  3. Yogen Saunthararajah · 1 shared paper, 2020 · strength 0.10
  4. Smitha Krishnamurthi · 1 shared paper, 2020 · strength 0.10
  5. Robert T. Dorr · 2 shared papers, 2012–2015 · strength 0.09
  6. Betty K. Samulitis · 2 shared papers, 2012–2015 · strength 0.09
  7. Elena V. Sheveleva · 1 shared paper, 2012 · strength 0.04
  8. Garth Powis · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.